These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37304234)

  • 1. LncRNA CACNA1G-AS1 up-regulates FTH1 to inhibit ferroptosis and promote malignant phenotypes in ovarian cancer cells.
    Jin Y; Qiu J; Lu X; Ma Y; Li G
    Oncol Res; 2023; 31(2):169-179. PubMed ID: 37304234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer.
    Li L; Zeng J; He S; Yang Y; Wang C
    Cancer Biol Ther; 2024 Dec; 25(1):2349429. PubMed ID: 38738555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of lncRNAs involved in m6A regulation for patients with ovarian cancer.
    Zheng J; Guo J; Cao B; Zhou Y; Tong J
    Cancer Cell Int; 2021 Jul; 21(1):363. PubMed ID: 34238292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-MYC Inhibited Ferroptosis and Promoted Immune Evasion in Ovarian Cancer Cells through NCOA4 Mediated Ferritin Autophagy.
    Jin Y; Qiu J; Lu X; Li G
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by Targeting microRNA-587/solute carrier family 7 member 11 axis in epithelial ovarian cancer.
    Cai L; Hu X; Ye L; Bai P; Jie Y; Shu K
    Bioengineered; 2022 Apr; 13(4):8226-8239. PubMed ID: 35311457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSUN5-FTH1 Axis Inhibits Ferroptosis to Promote the Growth of Gastric Cancer Cells.
    Su Y; Liu J; Zheng Z; Shi L; Huang W; Huang X; Ye C; Qi J; Wang W; Zhuang H
    Cell Biochem Biophys; 2023 Sep; 81(3):553-560. PubMed ID: 37528314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SP1-induced lncRNA MCF2L-AS1 promotes cisplatin resistance in ovarian cancer by regulating IGF2BP1/IGF2/MEK/ERK axis.
    Zhu Y; Yang L; Wang J; Li Y; Chen Y
    J Gynecol Oncol; 2022 Nov; 33(6):e75. PubMed ID: 36245227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Long Non-Coding RNA (lncRNA) AGAP2-AS1 is Upregulated in Ovarian Carcinoma and Negatively Regulates lncRNA MEG3.
    Chen J; Peng X; Dai Y
    Med Sci Monit; 2019 Jun; 25():4699-4704. PubMed ID: 31233485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetically silenced lncRNA SNAI3-AS1 promotes ferroptosis in glioma via perturbing the m
    Zheng J; Zhang Q; Zhao Z; Qiu Y; Zhou Y; Wu Z; Jiang C; Wang X; Jiang X
    J Exp Clin Cancer Res; 2023 May; 42(1):127. PubMed ID: 37202791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3-mediated m6A modification of lnc RNA RHPN1-AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K/AKT pathway.
    Cui S
    J Clin Lab Anal; 2022 Dec; 36(12):e24761. PubMed ID: 36336887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA CDKN2A-AS1 facilitates tumorigenesis and progression of epithelial ovarian cancer via modulating the SOSTDC1-mediated BMP-SMAD signaling pathway.
    Zhao Q; Dong D; Chu H; Man L; Huang X; Yin L; Zhao D; Mu L; Gao C; Che J; Liu Q
    Cell Cycle; 2021 Jun; 20(12):1147-1162. PubMed ID: 34110955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease.
    Tian Y; Lu J; Hao X; Li H; Zhang G; Liu X; Li X; Zhao C; Kuang W; Chen D; Zhu M
    Neurotherapeutics; 2020 Oct; 17(4):1796-1812. PubMed ID: 32959272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated lncRNA CACNA1G-AS1 aggravates the progression of colorectal cancer by downregulating p53.
    Wei LJ; Bai DM; Wang ZY; Liu BC
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):130-136. PubMed ID: 31957825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z; Kun W; Xiaochun S; Lingling T
    Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1.
    Wang J; Ding W; Xu Y; Tao E; Mo M; Xu W; Cai X; Chen X; Yuan J; Wu X
    Aging (Albany NY); 2020 Mar; 12(5):4558-4572. PubMed ID: 32163372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CACNA1G-AS1 promotes cell migration, invasion and epithelial-mesenchymal transition by HNRNPA2B1 in non-small cell lung cancer.
    Yu PF; Kang AR; Jing LJ; Wang YM
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):993-1002. PubMed ID: 29509247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z; Gao S; Xuan L; Liu X
    J Cell Mol Med; 2020 Apr; 24(7):4275-4285. PubMed ID: 32135030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway.
    Yang J; Li C; Li H; E C
    J Cell Physiol; 2019 Aug; 234(10):18415-18422. PubMed ID: 30908634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
    Gong YB; Zou YF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
    Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
    J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.